Testing effectiveness (Phase 2)Study completedNCT03987295
What this trial is testing
Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
Who this might be right for
Frontotemporal Dementia
Alector Inc. 33
Showing 20 of 24 results